TR-1: Standard form for notification of major holdings Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 14 August 2018 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are at- MEDICLINIC INTERNATIONAL PLC tached i 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for the notification (please mark the appropriate box or boxes with an “X”) An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Details of person subject to the notification obligation Name Coronation Asset Management (Pty) Ltd acting as dis- cretionary investment manager on behalf of managed portfolios. City and country of registered office (if applicable) Cape Town, South Africa 4. Full name of shareholder(s) (if different from 3.) Name N/A City and country of registered office (if applicable) 5. Date on which the threshold was crossed or reached: 13/08/2018 6. Date on which issuer notified (DD/MM/YYYY): 13/08/2018 7. Total positions of person(s) subject to the notification obligation % of voting rights at- % of voting rights Total of both in % Total number of tached to shares (to- through financial instru- (8.A + 8.B) voting rights of is- tal of 8. A) ments suer (total of 8.B 1 + 8.B 2) Resulting situation on the date on which 3.98% 3.98% 737 243 810 threshold was crossed or reached Position of previous notification (if 4.92% 4.92% applicable) 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached A: Voting rights attached to shares Class/type of shares Number of voting rights % of voting rights ISIN code (if possible) Direct Indirect Direct Indirect (Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive 2004/109/EC) (DTR5.1) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.2.1) (DTR5.2.1) GB00B8HX8Z88 29 352 830 3.98% SUBTOTAL 8. A 29 352 830 3.98% B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) Number of voting rights Type of financial in- Expiration Exercise/ that may be acquired if % of voting rights strument date Conversion Period the instrument is exercised/converted. SUBTOTAL 8. B 1 B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) Exercise/ Physical or Type of financial Expiration Conversion Pe- cash Number of % of voting rights instrument date riod settlement voting rights SUBTOTAL 8.B.2 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”) Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) is- suer Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal en- X tity (please add additional rows as necessary) % of voting rights Name xv % of voting rights through financial Total of both if it equals or is if it equals or is instruments if it higher than the notifiable higher than the equals or is higher threshold notifiable thresh- than the notifiable old threshold Coronation Fund Managers Ltd Coronation Investment Man- agement SA (Pty) Ltd Coronation Asset Management (Pty) Ltd 3.98% 3.98% 10. In case of proxy voting, please identify: Name of the proxy holder The number and % of voting rights held The date until which the voting rights will be held 11. Additional information Place of completion Cape Town, South Africa Date of completion 13/08/2018 Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. For further information, please contact: Company Secretary, Link Company Matters Limited Jayne Meacham / Caroline Emmet +44 (0)20 7954 9569 Investor Relations, Mediclinic International plc James Arnold, Head of Investor Relations ir@mediclinic.com +44 (0)20 3786 8181 Media queries FTI Consulting Brett Pollard/Debbie Scott – UK +44 (0)20 3727 1000 Sherryn Schooling – South Africa +27 (0)21 487 9000 Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom Website: www.mediclinic.com Corporate broker: Morgan Stanley & Co International plc JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd Date: 14/08/2018 01:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.